What is Medicinova, Inc.'s Market Cap?

Medicinova, Inc.'s Market Cap is $68.4M, based on as-reported figures from SEC (XBRL) filings.

What is Medicinova, Inc.'s Enterprise Value?

Medicinova, Inc.'s Enterprise Value is $43.0M, based on as-reported figures from SEC (XBRL) filings.

What is Medicinova, Inc.'s Price / Sales?

Medicinova, Inc.'s Price / Sales is 74.3×, based on as-reported figures from SEC (XBRL) filings.

What is Medicinova, Inc.'s EV / Revenue?

Medicinova, Inc.'s EV / Revenue is 46.7×, based on as-reported figures from SEC (XBRL) filings.

What is Medicinova, Inc.'s EV / EBITDA?

Medicinova, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Medicinova, Inc.'s Revenue (TTM)?

Medicinova, Inc.'s Revenue (TTM) is $920.5K, based on as-reported figures from SEC (XBRL) filings.

What is Medicinova, Inc.'s Net Income (TTM)?

Medicinova, Inc.'s Net Income (TTM) is -$10.8M, based on as-reported figures from SEC (XBRL) filings.

What is Medicinova, Inc.'s EBITDA?

Medicinova, Inc.'s EBITDA is -$11.8M, based on as-reported figures from SEC (XBRL) filings.

What is Medicinova, Inc.'s Diluted EPS (TTM)?

Medicinova, Inc.'s Diluted EPS (TTM) is -0.22, based on as-reported figures from SEC (XBRL) filings.

What is Medicinova, Inc.'s EBITDA Margin?

Medicinova, Inc.'s EBITDA Margin is -1285.3%, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Medicinova, Inc.

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SNG8P4

1.39▼ 0.02 (-1.42%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 1.41
Day's Range: 1.39 – 1.42
52-Week Range: 1.17 – 3.90
Volume: 25.3K
Avg Volume: 641.9K

Share Statistics

Shares Outstanding
Employees: 6
Exchange: XNAS
Listed: 2006-12-07

Share count as of August 11, 2026

Medicinova, Inc. (MNOV) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Medicinova, Inc. (MNOV)

What is Medicinova, Inc.'s Market Cap?: Medicinova, Inc.'s Market Cap is $68.4M, based on as-reported figures from SEC (XBRL) filings.
What is Medicinova, Inc.'s Enterprise Value?: Medicinova, Inc.'s Enterprise Value is $43.0M, based on as-reported figures from SEC (XBRL) filings.
What is Medicinova, Inc.'s Price / Sales?: Medicinova, Inc.'s Price / Sales is 74.3×, based on as-reported figures from SEC (XBRL) filings.
What is Medicinova, Inc.'s EV / Revenue?: Medicinova, Inc.'s EV / Revenue is 46.7×, based on as-reported figures from SEC (XBRL) filings.
What is Medicinova, Inc.'s EV / EBITDA?: Medicinova, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Medicinova, Inc.'s Revenue (TTM)?: Medicinova, Inc.'s Revenue (TTM) is $920.5K, based on as-reported figures from SEC (XBRL) filings.
What is Medicinova, Inc.'s Net Income (TTM)?: Medicinova, Inc.'s Net Income (TTM) is -$10.8M, based on as-reported figures from SEC (XBRL) filings.
What is Medicinova, Inc.'s EBITDA?: Medicinova, Inc.'s EBITDA is -$11.8M, based on as-reported figures from SEC (XBRL) filings.
What is Medicinova, Inc.'s Diluted EPS (TTM)?: Medicinova, Inc.'s Diluted EPS (TTM) is -0.22, based on as-reported figures from SEC (XBRL) filings.
What is Medicinova, Inc.'s EBITDA Margin?: Medicinova, Inc.'s EBITDA Margin is -1285.3%, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · MNOVAs-filed SEC (XBRL) data